The immunopathogenesis of human immunodeficiency virus infection.

The human immunodeficiency virus (HIV) is probably the most intensively studied virus in the history of biomedical research. A large number of distinct isolates have been cloned and sequenced, and the genes of the virus and several of the protein products of these genes have been characterized1. Furthermore, many of the pathogenic mechanisms associated with HIV infection that lead to clinical disease have been established, such as the functional abnormalities and quantitative depletion of CD4 T lymphocytes that cause the profound immunosuppression characteristic of advanced HIV infection2. It is generally agreed that HIV itself has the primary role . . .

[1]  R. Detels,et al.  The Acquired Immunodeficiency Syndrome , 1983 .

[2]  W. Frankel,et al.  Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice , 1991, Nature.

[3]  T. Klimkait,et al.  In vitro effect of transforming growth factor-beta on progression of HIV-1 infection in primary mononuclear phagocytes. , 1991, Journal of immunology.

[4]  D. Markovitz,et al.  The role of mononuclear phagocytes in HTLV-III/LAV infection. , 1986, Science.

[5]  M. Malim,et al.  Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes , 1991, The Journal of experimental medicine.

[6]  N. Brousse,et al.  Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes. , 1990, The Journal of clinical investigation.

[7]  A. Fauci,et al.  Human immunodeficiency virus (HIV) infection in CD4+ T lymphocytes genetically deficient in LFA-1: LFA-1 is required for HIV-mediated cell fusion but not for viral transmission , 1991, The Journal of experimental medicine.

[8]  M. Puoti,et al.  Selective depletion in HIV infection of T cells that bear specific T cell receptor V beta sequences. , 1991, Science.

[9]  D. Richman,et al.  Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro , 1989, The Journal of experimental medicine.

[10]  E. Palmer,et al.  Requirement for cotolerogenic gene products in the clonal deletion of I-E reactive T cells. , 1990, Science.

[11]  J. Sidtis,et al.  The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. , 1988, Science.

[12]  A. Fauci,et al.  Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infections. , 1991, Annals of the New York Academy of Sciences.

[13]  Lange,et al.  Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates , 1989, Journal of virology.

[14]  J. Armstrong,et al.  Retroviral infection of accessory cells and the immunological paradox in AIDS. , 1985, Immunology today.

[15]  A. Wyllie,et al.  Death and the cell. , 1986, Immunology today.

[16]  G. Linette,et al.  HIV-1-infected T cells show a selective signaling defect after perturbation of CD3/antigen receptor. , 1988, Science.

[17]  Edgar G. Engleman,et al.  pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane , 1987, Cell.

[18]  M. Cronin,et al.  Transforming growth factor beta and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[19]  N. Yamamoto,et al.  Mycoplasma can enhance HIV replication in vitro: a possible cofactor responsible for the progression of AIDS. , 1990, Biochemical and biophysical research communications.

[20]  J Leibowitch,et al.  Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). , 1983, Science.

[21]  D. Burke,et al.  Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes , 1988, The Journal of experimental medicine.

[22]  B. Cullen,et al.  Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. , 1991, Science.

[23]  J. Habeshaw,et al.  AIDS pathogenesis: HIV envelope and its interaction with cell proteins. , 1990, Immunology today.

[24]  J. Levy,et al.  The FC and not CD4 receptor mediates antibody enhancement of HIV infection in human cells. , 1989, Disease markers.

[25]  D. Richman,et al.  Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. , 1991, The Journal of clinical investigation.

[26]  A. Fauci,et al.  The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. , 1988, Science.

[27]  J. Wasserman,et al.  Immunological changes in primary HIV‐1 infection , 1990, AIDS.

[28]  A. Capron,et al.  Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals , 1992, The Journal of experimental medicine.

[29]  E. Werner,et al.  Interferon-gamma concentrations are increased in sera from individuals infected with human immunodeficiency virus type 1. , 1989, Journal of acquired immune deficiency syndromes.

[30]  S. Nakamura,et al.  Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. , 1992, Science.

[31]  R. Axel,et al.  HIV infection does not require endocytosis of its receptor, CD4 , 1988, Cell.

[32]  W. O'brien,et al.  Cytokines alter production of HIV-1 from primary mononuclear phagocytes. , 1988, Science.

[33]  J. Salmon,et al.  Phorbol ester-mediated induction of HIV-1 from a chronically infected promonocyte clone: blockade by protein kinase inhibitors and relationship to tat-directed trans-activation. , 1990, Biochemical and biophysical research communications.

[34]  I. Weissman,et al.  Mouse lymph node germinal centers contain a selected subset of T cells--the helper phenotype. , 1982, Journal of immunology.

[35]  W. Haseltine,et al.  Molecular biology of the human immunodeficiency virus type 1 , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  R. Steinman,et al.  The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.

[37]  F. Miedema,et al.  Non‐mitogenic T cell activation signals are sufficient for induction of human immunodeficiency virus transcription , 1991, European journal of immunology.

[38]  A. Fauci,et al.  Heat shock induction of HIV production from chronically infected promonocytic and T cell lines. , 1990, Journal of immunology.

[39]  P. Marrack,et al.  Evidence for the effects of a superantigen in rheumatoid arthritis. , 1991, Science.

[40]  C. Rosen,et al.  HIV regulatory proteins: potential targets for therapeutic intervention. , 1992, AIDS research and human retroviruses.

[41]  A. Fauci,et al.  Activated B lymphocytes from human immunodeficiency virus-infected individuals induce virus expression in infected T cells and a promonocytic cell line, U1 , 1991, The Journal of experimental medicine.

[42]  R. Schooley,et al.  Activity of interferons alpha, beta, and gamma against human immunodeficiency virus replication in vitro. , 1987, AIDS research and human retroviruses.

[43]  A. Cerami,et al.  Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses , 1988, The Journal of cell biology.

[44]  S. Salahuddin,et al.  Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients , 1990, Nature.

[45]  A. Fauci,et al.  The effect of cytokines and pharmacologic agents on chronic HIV infection. , 1992, AIDS research and human retroviruses.

[46]  Jerome A. Zack,et al.  HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure , 1990, Cell.

[47]  J. Justement,et al.  Retinoic acid mimics transforming growth factor beta in the regulation of human immunodeficiency virus expression in monocytic cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[48]  S. Orrenius,et al.  Calcium-dependent killing of immature thymocytes by stimulation via the CD3/T cell receptor complex. , 1989, Journal of immunology.

[49]  A. Fauci,et al.  Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines. , 1989, Science.

[50]  C A Smith,et al.  Antigen‐induced apoptosis in developing t cells: a mechanism for negative selection of the t cell receptor repertoire* , 1989, European journal of immunology.

[51]  M. Patarroyo,et al.  The leukocyte adhesion glycoprotein CD18 participates in HIV-1-induced syncytia formation in monocytoid and T cells. , 1990, Journal of immunology.

[52]  P. Wilkinson,et al.  Lymphocyte locomotion and migration. , 1981, Progress in allergy.

[53]  J. Zack,et al.  Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle , 1992, Journal of virology.

[54]  C. Fox,et al.  Recombinant gp120 specifically enhances tumor necrosis factor-alpha production and Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors. , 1991, Journal of immunology.

[55]  P. Marrack,et al.  A superantigen encoded in the open reading frame of the 3′ long terminal repeat of mouse mammary tumour virus , 1991, Nature.

[56]  G. Nabel,et al.  Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[57]  R. Pabst,et al.  Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system? , 1990, Immunology today.

[58]  H. Gendelman,et al.  Interferons in the persistence, pathogenesis, and treatment of HIV infection. , 1992, AIDS research and human retroviruses.

[59]  B. Walker,et al.  HIV-specific cytotoxic T lymphocytes in seropositive individuals , 1987, Nature.

[60]  J. Justement,et al.  Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[61]  M. Baseler,et al.  Infection of CD8+ T lymphocytes with HIV. Requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells. , 1991, Journal of immunology.

[62]  W. Blattner,et al.  HIV causes AIDS. , 1988, Science.

[63]  J. Hoxie,et al.  Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV. , 1986, Science.

[64]  G. F. Burton,et al.  Follicular Dendritic Cells as Accessory Cells , 1990, Immunological reviews.

[65]  A. Fauci,et al.  In vivo T lymphocyte origin of macrophage-tropic strains of HIV. Role of monocytes during in vitro isolation and in vivo infection. , 1990, Journal of immunology.

[66]  B. Autran,et al.  AIDS virus-specific cytotoxic T lymphocytes in lung disorders , 1987, Nature.

[67]  G. Williams,et al.  Recombinant human interferon-beta suppresses the replication of HIV and acts synergistically with AZT. , 1989, Journal of interferon research.

[68]  J. Phair,et al.  Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS , 1991, The Lancet.

[69]  D. Montefiori,et al.  Complement-mediated, antibody-dependent enhancement of HIV-1 infection in vitro is characterized by increased protein and RNA syntheses and infectious virus release. , 1989, Journal of acquired immune deficiency syndromes.

[70]  J. Mcdougal,et al.  Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen. , 1985, Journal of immunology.

[71]  O. Strannegard,et al.  Zidovudine in the management of primary HIV‐1 infection , 1991, AIDS.

[72]  R. Redfield,et al.  Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease , 1992, Journal of virology.

[73]  J. Sodroski,et al.  Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity , 1986, Nature.

[74]  H. Stein,et al.  Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells. , 1992, The American journal of pathology.

[75]  A. Fauci,et al.  Anti-CD2 receptor antibodies activate the HIV long terminal repeat in T lymphocytes. , 1991, Journal of immunology.

[76]  M. Greaves,et al.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus , 1984, Nature.

[77]  C. Janeway MIs: makes a little sense , 1991, Nature.

[78]  P. Marrack,et al.  A maternally inherited superantigen encoded by a mammary tumour virus , 1991, Nature.

[79]  D. Golde,et al.  Differentiating agents facilitate infection of myeloid leukemia cell lines by monocytotropic HIV-1 strains. , 1990, Blood.

[80]  D. Ho,et al.  Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. , 1991, The New England journal of medicine.

[81]  R. Mittler,et al.  Synergism between HIV gp120 and gp120-specific antibody in blocking human T cell activation. , 1989, Science.

[82]  J. Gerdes,et al.  Isolation of normal human follicular dendritic cells and CD4‐independent in vitro infection by human immunodeficiency virus (HIV‐1) , 1991, European journal of immunology.

[83]  C. Fox,et al.  Dissociation between syncytia formation and HIV spreading. Suppression of syncytia formation does not necessarily reflect inhibition of HIV infection , 1991, European journal of immunology.

[84]  A. Fauci,et al.  Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. , 1989, Journal of immunology.

[85]  K. Kalland,et al.  Replication of human immunodeficiency virus type 1 in primary dendritic cell cultures. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[86]  H. Gendelman,et al.  Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. , 1986, Science.

[87]  H. Gendelman,et al.  Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[88]  P. Luciw,et al.  Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat. , 1989, Journal of immunology.

[89]  A. Fauci,et al.  Induction of expression of human immunodeficiency virus in a chronically infected promonocytic cell line by ultraviolet irradiation. , 1989, AIDS research and human retroviruses.

[90]  E. Palmer,et al.  The MHC molecule I-E is necessary but not sufficient for the clonal deletion of V beta 11-bearing T cells , 1989, The Journal of experimental medicine.

[91]  P. Marrack,et al.  Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex , 1988, Nature.

[92]  A. Fauci,et al.  Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. , 1990, Immunology today.

[93]  R. Gallo,et al.  Hydrocortisone and some other hormones enhance the expression of HTLV‐III , 1986, International journal of cancer.

[94]  J. Justement,et al.  Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells , 1992, The Journal of experimental medicine.

[95]  R. Abe,et al.  Analysis of Mlsc genetics. A novel instance of genetic redundancy , 1989, The Journal of experimental medicine.

[96]  C. Atkin,et al.  The Mycoplasma arthritidis T-cell mitogen, MAM: a model superantigen. , 1991, Immunology today.

[97]  R. Gallo,et al.  Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[98]  M. Dietrich,et al.  ALTERED FOLLICULAR DENDRITIC CELLS AND VIRUS-LIKE PARTICLES IN AIDS AND AIDS-RELATED LYMPHADENOPATHY , 1985, The Lancet.

[99]  R. Schooley,et al.  RECOMBINANT HUMAN INTERFERON ALFA-A SUPPRESSES HTLV-III REPLICATION IN VITRO , 1985, The Lancet.

[100]  P. J. Dyson,et al.  Genes encoding ligands for deletion of Vβ11 T cells cosegregate with mammary tumour virus genomes , 1991, Nature.

[101]  S. Nakamura,et al.  AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. , 1989, Science.

[102]  Luc Montagnier,et al.  T-lymphocyte T4 molecule behaves as the receptor for human retrovirus  LAV , 1984, Nature.

[103]  O. Bagasra,et al.  Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction. , 1992, The New England journal of medicine.

[104]  R. Zinkernagel,et al.  T-cell receptor Vβ use predicts reactivity and tolerance to Mlsa- encoded antigens , 1988, Nature.

[105]  A. Fauci,et al.  Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[106]  S. J. Clark,et al.  High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. , 1991, The New England journal of medicine.

[107]  H. Robson MacDonald,et al.  Clonal deletion of V β814-bearing T cells in mice transgenic for mammary tumour virus , 1991, Nature.

[108]  E. Palmer,et al.  An endogenous retrovirus mediating deletion of αβ T cells? , 1991, Nature.

[109]  S W Lagakos,et al.  Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection , 1990 .

[110]  A. Fauci,et al.  Induction of expression of HIV in latently or chronically infected cells. , 1989, AIDS research and human retroviruses.

[111]  D. Abrams,et al.  Persistent diffuse lymphadenopathy in homosexual men: endpoint or prodrome? , 1984, Annals of internal medicine.

[112]  B. Nathwani,et al.  Human immunodeficiency viral DNA is readily found in lymph node biopsies from seropositive individuals. Analysis of fixed tissue using the polymerase chain reaction. , 1989, The American journal of pathology.

[113]  Gwyn T. Williams,et al.  Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures , 1989, Nature.

[114]  J. Justement,et al.  Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. , 1987, Science.

[115]  M. Newell,et al.  Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen , 1990, Nature.

[116]  J. Seigneurin,et al.  HIV-1 in blood monocytes: frequency of detection of proviral DNA using PCR and comparison with the total CD4 count. , 1992, AIDS research and human retroviruses.

[117]  R. Orentas,et al.  Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation. , 1989, Science.

[118]  G. Schiavo,et al.  CD4 epitope masking by gp120/anti-gp120 antibody complexes. A potential mechanism for CD4+ cell function down-regulation in AIDS patients. , 1992, Journal of immunology.

[119]  A. Fauci,et al.  Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells , 1990, Journal of virology.

[120]  C. Kufta,et al.  Specific tropism of HIV-1 for microglial cells in primary human brain cultures. , 1990, Science.

[121]  T. Holzer,et al.  The effect of interleukin 4 (BSF-1) on infection of peripheral blood monocyte-derived macrophages with HIV-1. , 1991, Disease markers.

[122]  F. Miedema,et al.  Programmed death of T cells in HIV-1 infection. , 1992, Science.

[123]  M. Dietrich,et al.  HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS. , 1986, The American journal of pathology.

[124]  M. McElrath,et al.  Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[125]  G. Beall,et al.  Infection with HIV is associated with elevated IL-6 levels and production. , 1990, Journal of immunology.

[126]  M. Grieco,et al.  Tumor necrosis factor and HIV P24 antigen levels in serum of HIV-infected populations. , 1988, Journal of acquired immune deficiency syndromes.

[127]  A. Fauci,et al.  Lymphoid organs function as major reservoirs for human immunodeficiency virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[128]  P. Marrack,et al.  V beta-specific stimulation of human T cells by staphylococcal toxins. , 1989, Science.

[129]  J. Lifson,et al.  AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. , 1986, Science.

[130]  M. Helbert T-cell receptor variable gene products and early HIV-1 infection. , 1992 .

[131]  D. Nixon,et al.  HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides , 1988, Nature.

[132]  J. McKeating,et al.  Tumour necrosis factors (alpha, beta) induced by HIV-1 in peripheral blood mononuclear cells potentiate virus replication. , 1990, AIDS.

[133]  L. Montagnier,et al.  The cytopathic effect of HIV is associated with apoptosis. , 1991, Virology.

[134]  S. Patterson,et al.  Effect of Human Immunodeficiency Virus on Dendritic Cells Isolated from Human Peripheral Blood , 1989 .

[135]  A. Capron,et al.  Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. , 1991, Immunology today.

[136]  J. Justement,et al.  Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[137]  J. Chermann,et al.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). , 1983, Science.

[138]  R. Garry,et al.  Potential mechanisms for the cytopathic properties of HIV. , 1989, AIDS.

[139]  H. Balfour,et al.  Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cocultures. Involvement of transforming growth factor-beta. , 1991, Journal of immunology.

[140]  M. Clerici,et al.  Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals. , 1989, The Journal of clinical investigation.

[141]  G. Morel,et al.  Human immunodeficiency virus type 1 infection of U937 cells promotes cell differentiation and a new pathway of viral assembly. , 1990, Virology.

[142]  L. Kingsley,et al.  The effect of antiviral therapy on the natural history of human immunodeficiency virus infection in a cohort of hemophiliacs. , 1992, Journal of acquired immune deficiency syndromes.

[143]  J. Merrill,et al.  HIV‐1, macrophages, glial cells, and cytokines in AIDS nervous system disease , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[144]  H. Schuitemaker,et al.  Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages. , 1992, The Journal of clinical investigation.

[145]  J. Laurence,et al.  Effect of Glucocorticoids on Chronic Human Immunodeficiency Virus (HIV) Infection and HIV Promoter-Mediated Transcription , 1989 .

[146]  E. Gelmann,et al.  The Acquired Immunodeficiency Syndrome: An Update , 1985 .

[147]  D. Bolognesi HIV antibodies and vaccine design , 1989, AIDS.

[148]  C H Fox,et al.  The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. , 1989, Science.

[149]  J. Justement,et al.  Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage , 1991, The Journal of experimental medicine.

[150]  T. Schulz,et al.  The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion? , 1991, AIDS research and human retroviruses.

[151]  H. Mitsuya,et al.  Molecular targets for AIDS therapy. , 1990, Science.

[152]  K. Frei,et al.  Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid , 1989, Journal of Neuroimmunology.

[153]  H. Rammensee,et al.  Clonal anergy induced in mature Vβ6+ T lymphocytes on immunizing Mls-1b mice with Mls-1a expressing cells , 1989, Nature.

[154]  M P Dempsey,et al.  Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. , 1991, Science.

[155]  A. Fauci,et al.  Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[156]  M. Roederer,et al.  N-acetylcysteine: a new approach to anti-HIV therapy. , 1992, AIDS research and human retroviruses.

[157]  B. Spire,et al.  Induction of NF-KB during monocyte differentiation by HIV type 1 infection. , 1991, Journal of immunology.

[158]  P. Baeuerle,et al.  Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1. , 1991, The EMBO journal.

[159]  J. Sprent,et al.  Extrathymic tolerance of mature T cells: Clonal elimination as a consequence of immunity , 1990, Cell.

[160]  M. Gardner,et al.  Human alpha- and beta-interferon but not gamma- suppress the in vitro replication of LAV, HTLV-III, and ARV-2. , 1986, Journal of interferon research.

[161]  C. Fox,et al.  Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA. , 1991, The Journal of infectious diseases.

[162]  J. Justement,et al.  Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms , 1990, The Journal of experimental medicine.

[163]  A. Fauci,et al.  Immunopathogenesis of HIV infection , 1991, Journal of acquired immune deficiency syndromes.